GlassScriptPhysician profile
Gloria Johnson
NPI 1346792751
$2,602.04
in general payments reported to CMS, 2019-2025
19 companies · $1,982 in 2025
The $1,982 reported for 2025 was more than what 93% of Adult Health (Nurse Practitioner) providers received nationally (typical 2025 total: $182).
See the full distribution for Adult Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $328 · 2023: $103 · 2024: $188 · 2025: $1,982.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,274.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,273.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $1,078.71 | 2024-2025 | Breztri, Airsupra, Farxiga |
| Novo Nordisk INC | $230.11 | 2022-2025 | Ozempic, Rybelsus |
| Abbvie INC. | $207.54 | 2025 | |
| Esperion Therapeutics, INC. | $150.00 | 2022 | |
| Phathom Pharmaceuticals, INC. | $149.99 | 2024 | Voquezna |
| Viiv Healthcare Company | $125.00 | 2025 | Cabenuva |
| Intra-Sana Laboratories | $107.91 | 2025 | Reltone 200 Mg, Glycate, Reltone 400 Mg |
| Coloplast Corp | $101.97 | 2022 | |
| Astellas Pharma US INC | $91.83 | 2025 | Veozah |
| Axsome Therapeutics, INC. | $86.09 | 2025 | Symbravo |
| Sumitomo Pharma America, INC. | $84.96 | 2023 | Gemtesa |
| Otsuka America Pharmaceutical, INC. | $40.24 | 2023-2025 | Abilify Maintena, Rexulti |
| Agios Pharmaceuticals, INC. | $29.34 | 2025 | Pyrukynd |
| Gilead Sciences, INC. | $24.84 | 2025 | |
| Valinor Pharma, LLC | $22.54 | 2025 | Movantik |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $19.74 | 2025 | |
| Teva Pharmaceuticals USA, INC. | $18.81 | 2025 | Austedo Xr |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $18.50 | 2025 | Caplyta |
| Exact Sciences Corporation | $13.92 | 2024 | Cologuard Collection Kit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gloria Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.